Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Valerio Tozzi"'
Autor:
Maria Letizia Giancola, Patrizia Lorenzini, Antonella Cingolani, Francesco Baldini, Simona Bossolasco, Teresa Bini, Laura Monno, Giovanna Picchi, Antonella d’Arminio Monforte, Paola Cinque, Valerio Tozzi, Andrea Antinori
Publikováno v:
AIDS Research and Treatment, Vol 2012 (2012)
The aim of the present study was to analyse the effect of antiretroviral (ARV) therapy and single antiretroviral drugs on cerebrospinal fluid (CSF) HIV-RNA burden in HIV-infected patients affected by neurological disorders enrolled in a multicentric
Externí odkaz:
https://doaj.org/article/772d695a49424e48a7dfc0a7f7216a3c
Autor:
Guido Palamara, Alessandra Latini, Evangelo Boumis, Carlo Federico Perno, Chiara Tommasi, Federica Forbici, Claudia Alteri, Francesca Ceccherini-Silberstein, Rita Bellagamba, Caterina Gori, Maria Mercedes Santoro, Andrea Antinori, Pasquale Narciso, Daniele Armenia, Raffaella Libertone, Carmela Pinnetti, Vanni Borghi, Mario Santoro, Emanuele Nicastri, Cristina Mussini, Lavinia Fabeni, Adriana Ammassari, Valerio Tozzi, Andrea Calcagno, Valentina Svicher, Massimo Andreoni, Giovanni Di Perri, Philippe Flandre, A. R. Buonomini
Publikováno v:
Antiviral Therapy; Vol 18
Background We tested whether pre-HAART viraemia affects the achievement and maintenance of virological success in HIV-1-infected patients starting modern first-line therapies. Methods A total of 1,430 patients starting their first HAART (genotype-tai
Autor:
Simona Bossolasco, Antonella Cingolani, Valerio Tozzi, Maria Letizia Giancola, Teresa Bini, Patrizia Lorenzini, Paola Cinque, Andrea Antinori, Laura Monno, Giovanna Picchi, Antonella d'Arminio Monforte, Francesco Baldini
Publikováno v:
AIDS Research and Treatment
AIDS Research and Treatment, Vol 2012 (2012)
AIDS Research and Treatment, Vol 2012 (2012)
The aim of the present study was to analyse the effect of antiretroviral (ARV) therapy and single antiretroviral drugs on cerebrospinal fluid (CSF) HIV-RNA burden in HIV-infected patients affected by neurological disorders enrolled in a multicentric
Autor:
Vincenzo Fragola, Rita Bellagamba, M Massella, R De Vita, Pasquale Narciso, M Rizzica, Luca Fracasso, Valerio Tozzi, Jelena Ivanovic
Publikováno v:
Patient Preference and Adherence, Vol 2011, Iss default, Pp 223-228 (2011)
Patient preference and adherence
Patient preference and adherence
M Massella¹, J Ivanovic², R Bellagamba², R De Vita³, L Fracasso³, V Tozzi², V Fragola¹, M Rizzica², P Narciso²¹Istituto Superiore Sanità, Rome, Italy; ²National Institute for Infectious Disease – Lazzaro Spallanzani, Rome, Italy; ³Regi
Autor:
Valerio Tozzi
Publikováno v:
Antiviral Research. 85:190-200
The introduction of highly active antiretroviral therapy (HAART) as standard of care has changed the natural history of HIV infection into a manageable chronic disease requiring long-term antiretroviral (ARV) treatment. However, response to HAART is
Autor:
Maria Letizia Giancola, Giuseppina Liuzzi, Andrea Antinori, Pasquale Narciso, Pietro Balestra, Maria Flora Salvatori, Chrysoula Vlassi, Valerio Tozzi, Marinella Giulianelli
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 52:56-63
Although HIV-associated neurocognitive disorders should be treated with highly active antiretroviral treatment (HAART) regimens with good central nervous system (CNS) penetration, the definition of neuroactive HAART remains controversial. We compared
Autor:
Jelena, Ivanovic, Ivanovic, Jelena, Emanuele, Nicastri, Nicastri, Emanuele, Paolo, Ascenzi, Ascenzi, Paolo, Rita, Bellagamba, Bellagamba, Rita, Elisabetta, De Marinis, De Marinis, Elisabetta, Stefania, Notari, Notari, Stefania, Leopoldo Paolo, Pucillo, Pucillo Leopoldo, Paolo, Valerio, Tozzi, Tozzi, Valerio, Giuseppe, Ippolito, Ippolito, Giuseppe, Pasquale, Narciso, Narciso, Pasquale
Publikováno v:
Current Medicinal Chemistry. 15:1925-1939
The rate of HIV-positive patients that fails to reach or to maintain a durable virological suppression under anti-retroviral (ARV) therapy might be as high as 50%, therefore new tools to improve ARV drug efficacy are urgently needed. Among others, th
Publikováno v:
Current HIV research
6 (2008): 363–369. doi:10.2174/157016208785132464
info:cnr-pdr/source/autori:Cappuccio, Antonio; Castiglione, Filippo; Piccoli, Benedetto; Tozzi, Valerio/titolo:Evaluation of HIV-1 and CD4+ T cell dynamic parameters in patients treated with genotypic resistance testing-guided HAART/doi:10.2174%2F157016208785132464/rivista:Current HIV research (Print)/anno:2008/pagina_da:363/pagina_a:369/intervallo_pagine:363–369/volume:6
6 (2008): 363–369. doi:10.2174/157016208785132464
info:cnr-pdr/source/autori:Cappuccio, Antonio; Castiglione, Filippo; Piccoli, Benedetto; Tozzi, Valerio/titolo:Evaluation of HIV-1 and CD4+ T cell dynamic parameters in patients treated with genotypic resistance testing-guided HAART/doi:10.2174%2F157016208785132464/rivista:Current HIV research (Print)/anno:2008/pagina_da:363/pagina_a:369/intervallo_pagine:363–369/volume:6
The extent of immune restoration in HIV-1 patients on antiretroviral therapy is an important marker of disease progression. In this work, we investigate the dynamics of immune reconstitution and address the question of whether the early response to a
Autor:
Valerio Tozzi, Gianpiero D'Offizi, Filippo Martini, Roberto Paganelli, Alessandra Sacchi, Cristiana Gioia, Fabrizio Poccia, Angela Corpolongo, Pasquale Narciso, Ilaria Volpi
Publikováno v:
International Journal of Immunopathology and Pharmacology. 20:473-485
In some early-treated HIV+ patients, Structured Treatment Interruption (STI) is associated to spontaneous control of viral rebound. Thus, in this clinical setting, we analyzed the immunological parameters associated to viral control. Two groups of ea
Autor:
Andrea Antinori, Pasquale Narciso, Pietro Balestra, Simonetta Galgani, Maria Flora Salvatori, Chrysoula Vlassi, Angela Corpolongo, Marinella Giulianelli, Valerio Tozzi, Ubaldo Visco-Comandini, Rita Bellagamba
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 45:174-182
Objective: Although highly active antiretroviral therapy (HAART) can reverse HIV-related neurocognitive impairment (NCI), neuropsychologic (NP) deficits may persist in a substantial proportion of patients despite antiretroviral treatment. We assessed